Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer-Reference-Cited by-同舟云学术

Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer

Published:2014-04 Issue:7 Volume:189 Page:832-844
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Germain Claire,Gnjatic Sacha,Tamzalit Fella,Knockaert Samantha,Remark Romain,Goc Jérémy,Lepelley Alice,Becht Etienne,Katsahian Sandrine,Bizouard Geoffray,Validire Pierre,Damotte Diane,Alifano Marco,Magdeleinat Pierre,Cremer Isabelle,Teillaud Jean-Luc,Fridman Wolf-Herman,Sautès-Fridman Catherine,Dieu-Nosjean Marie-Caroline

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference51 articles.

1. Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy

2. NY-ESO-1-Specific Circulating CD4+ T Cells in Ovarian Cancer Patients Are Prevalently TH1 Type Cells Undetectable in the CD25+FOXP3+Treg Compartment

3. Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients

4. Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients

5. Spontaneous CD8 T Cell Responses against the Melanocyte Differentiation Antigen RAB38/NY-MEL-1 in Melanoma Patients

Cited by 593 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tertiary lymphoid structures as potential biomarkers for cancer prediction and prognosis;International Immunopharmacology;2024-10

2. Clinical multi-dimensional prognostic nomogram for predicting the efficacy of immunotherapy in NSCLC;Scientific Reports;2024-09-13

3. Recruitment of CXCR4+ type 1 innate lymphoid cells distinguishes sarcoidosis from other skin granulomatous diseases;Journal of Clinical Investigation;2024-09-03

4. Macrophages and tertiary lymphoid structures as indicators of prognosis and therapeutic response in cancer patients;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

5. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances;Signal Transduction and Targeted Therapy;2024-08-28